Skip to main content
Premium Trial:

Request an Annual Quote

GE, Hamilton Developing FTA Workflow

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –GE Health and Hamilton Robotics today announced a licensing agreement and collaboration to develop an automated workflow for sample handling and processing from FTA substrates.

The deal focuses on challenges in high-throughput dried sample processing for applications including drug metabolism and pharmacogenetics, and human identification, Richard Dool, GE Healthcare's general manager for consumables, said in a statement. By removing process bottlenecks, his firm and Hamilton hope to "establish a new standard in efficiency and reliability."

Terms of the deal were not disclosed.

According to Radi Hofstetter, vice president of the Hamilton facility in Bonaduz, Switzerland, FTA paper is becoming the method of choice in forensic sample collection, processing, and storage. "Incorporating this technology into an automated workflow will afford higher throughput and efficiencies within forensics as well as in new areas of application, including" drug metabolism and pharmacogenetics, he said.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.